IDEAYA Biosciences, Inc. (IDYA)
Healthcare • Biotechnology
StockNasdaqGSUnited StatesUS45166A1025
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by IDEAYA Biosciences, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 15:29. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 16 Feb 2027 08:00 | -1.16 | — | — | Upcoming |
| 03 Nov 2026 06:00 | -1.16 | -1.22 | -4.9% | Miss |
| 04 Aug 2026 06:00 | -1.05 | -1.22 | -16.2% | Miss |
| 05 May 2026 06:00 | -0.98 | -1.11 | -13.5% | Miss |
| 17 Feb 2026 06:00 | -0.95 | -0.94 | +0.6% | In line |
| 04 Nov 2025 06:00 | -0.55 | 1.33 | +341.8% | Beat |
| 05 Aug 2025 06:00 | -0.79 | -0.88 | -10.8% | Miss |
| 06 May 2025 06:00 | -0.69 | -0.82 | -19.5% | Miss |
| 13 Feb 2025 06:00 | -0.62 | -1.49 | -139.4% | Miss |
| 04 Nov 2024 06:00 | -0.60 | -0.60 | +0.8% | In line |
| 06 Aug 2024 06:00 | -0.53 | -0.68 | -28.8% | Miss |
| 07 May 2024 06:00 | -0.50 | -0.53 | -5.5% | Miss |
| 20 Feb 2024 06:00 | -0.46 | -0.52 | -13.2% | Miss |
| 07 Nov 2023 06:00 | -0.50 | -0.46 | +7.3% | Beat |
| 10 Aug 2023 06:00 | -0.55 | -0.50 | +9.6% | Beat |
| 09 May 2023 06:00 | -0.54 | -0.49 | +8.9% | Beat |
| 07 Mar 2023 06:00 | -0.57 | -0.50 | +13.0% | Beat |
| 08 Nov 2022 06:00 | -0.62 | 0.04 | +106.4% | Beat |
| 15 Aug 2022 06:00 | -0.51 | -0.57 | -10.8% | Miss |
| 10 May 2022 06:00 | -0.42 | -0.36 | +13.9% | Beat |
| 15 Mar 2022 06:00 | -0.31 | -0.47 | -53.4% | Miss |
| 15 Nov 2021 06:00 | -0.31 | -0.31 | -0.3% | In line |
| 10 Aug 2021 06:00 | -0.08 | -0.33 | -293.7% | Miss |
| 10 May 2021 06:00 | -0.36 | -0.28 | +22.2% | Beat |
| 23 Mar 2021 06:00 | -0.26 | -0.18 | +29.5% | Beat |
| 12 Nov 2020 06:00 | 1.13 | -0.17 | -115.0% | Miss |
| 12 Aug 2020 06:00 | -0.62 | -0.59 | +4.8% | Beat |
| 12 May 2020 06:00 | -0.58 | -0.59 | -2.6% | Miss |
| 24 Mar 2020 06:00 | -0.57 | -0.53 | +7.3% | Beat |
| 13 Nov 2019 06:00 | -0.66 | -0.54 | +18.4% | Beat |
| 12 Aug 2019 16:00 | -0.64 | -0.52 | +18.4% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 218.7M | +3,024.4% | -113.7M | -52.0% | -1.28 | +61.9% | -73.5M |
| 2024 | 7M | -70.1% | -274.5M | -3,921.1% | -3.36 | -71.4% | -251.4M |
| 2023 | 23.4M | -54.1% | -113M | -483.0% | -1.96 | -38.0% | -117.6M |
| 2022 | 50.9M | — | -58.7M | -115.2% | -1.42 | — | -90.6M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 32.14 | 32.91 | 30.20 | 30.59 | -4.27% | 10,921,552 | |
| Oct 2026 | 38.34 | 39.32 | 31.70 | 31.96 | -16.81% | 18,832,900 | |
| Sep 2026 | 39.85 | 41.48 | 35.59 | 38.42 | -4.19% | 17,910,500 | |
| Aug 2026 | 35.13 | 42.68 | 34.56 | 40.10 | +12.96% | 15,610,600 | |
| Jul 2026 | 37.57 | 40.58 | 34.01 | 35.50 | -4.75% | 20,781,100 | |
| Jun 2026 | 29.38 | 38.21 | 26.81 | 37.27 | +26.47% | 33,210,500 | |
| May 2026 | 29.02 | 29.97 | 27.66 | 29.47 | +1.27% | 15,716,100 | |
| Apr 2026 | 33.50 | 38.10 | 27.97 | 29.10 | -12.67% | 35,831,500 | |
| Mar 2026 | 31.81 | 35.68 | 29.57 | 33.32 | +3.48% | 21,331,700 | |
| Feb 2026 | 32.19 | 34.66 | 29.47 | 32.20 | +0.03% | 16,219,700 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Mizuho Maintains Outperform on IDEAYA Biosciences, Lowers Price Target to $39 (opens in a new tab) Benzinga · 10 Nov 2026 13:40
- Citigroup Maintains Buy on IDEAYA Biosciences, Raises Price Target to $66 (opens in a new tab) Benzinga · 05 Nov 2026 18:22
- IDEAYA Biosciences, Inc. (IDYA) Reports Q3 Loss, Tops Revenue Estimates (opens in a new tab) Zacks · 03 Nov 2026 11:25
- Is IDEAYA Biosciences (IDYA) A Bargain Following Its ESMO 2026 Clinical Data? (opens in a new tab) Simply Wall St. · 31 Oct 2026 05:13
- IDEAYA Biosciences, Inc. (IDYA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (opens in a new tab) Zacks · 27 Oct 2026 13:00
- IDEAYA Biosciences (IDYA) Rethinks Its R And D Leadership As Undervaluation Questions Grow (opens in a new tab) Simply Wall St. · 08 Oct 2026 18:18
- Can IDEAYA Biosciences (IDYA) Turn Uncharted Oncology Territory Into Commercial Gold? (opens in a new tab) Insider Monkey · 25 Sep 2026 10:42
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 31.49 USD
- Market cap
- 3.0B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow IDYA and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.